@LauraMStapleton Ah sorry, not direct/indirect as used for mediation context. This figure gives the idea (from a paper that oddly says very little about simulation but has lots of interesting stuff about issues when planning trials in infectious diseases).
@camjpatrick Ah sorry, not direct/indirect as used in mediation. This figure gives the idea (from a paper that oddly says very little about simulation but has lots of interesting stuff about issues when planning trials in infectious diseases). https://t.co
RT @SeanCavany: Transmission coupling 🔗 must be dealt with using a dynamic transmission model, which should be used at all stages of such t…
RT @SeanCavany: Transmission coupling 🔗 must be dealt with using a dynamic transmission model, which should be used at all stages of such t…
Transmission coupling 🔗 must be dealt with using a dynamic transmission model, which should be used at all stages of such trials. For more on this topic, see this great review by @betzhallo: https://t.co/NwmDob6Orq 11/13
RT @biorxiv_pubd: Simulations for Designing and Interpreting Intervention Trials in Infectious Diseases published as: https://t.co/3ehF1zv1…
Simulations for Designing and Interpreting Intervention Trials in Infectious Diseases published as: https://t.co/3ehF1zv15L @BMCMedicine #biorxiv
RT @jonotter: #eccmid2018 Ben Cooper’s outstanding review on using modelling to inform decision making when planning interventions around I…
RT @jonotter: #eccmid2018 Ben Cooper’s outstanding review on using modelling to inform decision making when planning interventions around I…
RT @jonotter: #eccmid2018 Ben Cooper’s outstanding review on using modelling to inform decision making when planning interventions around I…
#eccmid2018 Ben Cooper’s outstanding review on using modelling to inform decision making when planning interventions around ID, HCAI and AMR https://t.co/eFqVtWixYi
@Drjulietmd @SHEA_Epi Also, in addition to a statistician, consider consulting your friendly local infectious disease modeler. We can help with everything from sample size calculations for complex study designs to helping explain quizzical results. https:/
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
Simulations for designing and interpreting intervention trials in infectious diseases https://t.co/4xv0kQnQ5b
RT @AdamJKucharski: Simulations for designing and interpreting intervention trials in infectious diseases https://t.co/PUoMW0StXh
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @AdamJKucharski: Simulations for designing and interpreting intervention trials in infectious diseases https://t.co/PUoMW0StXh
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @AdamJKucharski: Simulations for designing and interpreting intervention trials in infectious diseases https://t.co/PUoMW0StXh
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @GiGuR0: Important point made by @betzhallo @mlipsitch @alexvespi @bugwonk and others. https://t.co/aal4KJSzkw
RT @GiGuR0: Important point made by @betzhallo @mlipsitch @alexvespi @bugwonk and others. https://t.co/aal4KJSzkw
Simulations for designing and interpreting intervention trials in infectious diseases https://t.co/PUoMW0StXh
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
Important point made by @betzhallo @mlipsitch @alexvespi @bugwonk and others. https://t.co/aal4KJSzkw
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
RT @alexvespi: Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCM…
Simulations for designing and interpreting intervention trials in infectious diseases @betzhallo @mlipsitch et al. in @BMCMedicine https://t.co/hfH5YbqNAn https://t.co/l3OTp09yr7
RT @BMCMedicine: Simulations for designing and interpreting intervention #trials in #infectious #diseases https://t.co/2r6yMsGQph
Simulations for designing and interpreting intervention #trials in #infectious #diseases https://t.co/2r6yMsGQph